1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole has been researched along with omeprazole in 1 studies
Studies (1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole) | Trials (1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole) | Recent Studies (post-2010) (1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole) | Studies (omeprazole) | Trials (omeprazole) | Recent Studies (post-2010) (omeprazole) |
---|---|---|---|---|---|
29 | 2 | 4 | 9,085 | 2,737 | 1,487 |
Protein | Taxonomy | 1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole (IC50) | omeprazole (IC50) |
---|---|---|---|
Mcl-1 | Homo sapiens (human) | 3.1448 | |
cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.28 | |
Potassium-transporting ATPase alpha chain 1 | Homo sapiens (human) | 1.45 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 2.315 | |
Potassium-transporting ATPase subunit beta | Homo sapiens (human) | 1.45 | |
WD repeat-containing protein 5 | Homo sapiens (human) | 1.7 | |
Glutathione S-transferase omega-1 | Homo sapiens (human) | 4.6 | |
Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | 1.7 | |
Muscarinic acetylcholine receptor | Cavia porcellus (domestic guinea pig) | 3.8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barrett, DA; Goddard, AF; Jessa, MJ; Shaw, PN; Spiller, RC | 1 |
1 trial(s) available for 1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole and omeprazole
Article | Year |
---|---|
The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice.
Topics: Adult; Anti-Ulcer Agents; Antitrichomonal Agents; Area Under Curve; Biological Availability; Cross-Over Studies; Double-Blind Method; Gastric Juice; Half-Life; Humans; Male; Metabolic Clearance Rate; Metronidazole; Omeprazole; Saliva | 1997 |